A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants
Clinical trial NCT00322049 · COMPLETED
Trial details
- NCT number
- NCT00322049
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2009-06-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.